Cancellation of state registration. Altargo®

November 17, 2016

Active substances:

Retapamulin

Trade names:

Altargo®

ICD-10:

I.B95-B97.B95 Streptococci and staphylococci as a cause of diseases classified elsewhere

XII.L00-L08.L01 Impetigo

XII.L20-L30.L30.3 Infectious dermatitis

XIX.T79.T79.3 Post-traumatic wound infection, not elsewhere classified

Altargo, retapamulin, an antibiotic for external use, impetigo, wound infection, streptococcal infection, staphylococcal infection

The Ministry of Health of the Russian Federation in accordance with Article 32 of the FederalLaw of 12.04.2010 No. 61-FZ "On the circulation of medicines" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-001307 dated 29.11.2011 issued by GlaxoSmithKline Trading, Russia):

Altargo (trade name of the medicinal product)

Retapamulin (International Nonproprietary or Chemical Name of the Drug)

ointment for external use, 1 % (dosage form, dosage)

Glaxo United Kingdom Limited, United Kingdom Harmirc Road, Barnard Castle, Durham, DL12 8DT, United Kingdom (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the owner of the registration certificate of ZAO "GlaxoSmithKline Trading" abolition of state registration of the medicinal product.